On the basis of the above considerations, this narrative review aims to highlight the pathogenic role of TSLP in asthma, and also to provide an updated coverage of the therapeutic use of tezepelumab as add-on biologic therapy of severe asthma. The gene discussed is TSLP; the disease is asthma.